{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:34:30Z","timestamp":1780601670301,"version":"3.54.1"},"reference-count":15,"publisher":"Baishideng Publishing Group Inc.","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2008]]},"DOI":"10.3748\/wjg.14.3085","type":"journal-article","created":{"date-parts":[[2008,5,23]],"date-time":"2008-05-23T14:17:25Z","timestamp":1211552245000},"page":"3085","source":"Crossref","is-referenced-by-count":73,"title":["Is infliximab safe to use while breastfeeding?"],"prefix":"10.3748","volume":"14","author":[{"given":"Joel Z","family":"Stengel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hays L","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Jospe ES, Peppercorn MA. Inflammatory bowel disease and pregnancy: a review. Dig Dis 1999;17:201-207.","DOI":"10.1159\/000016937"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006;4:1255-1258.","DOI":"10.1016\/j.cgh.2006.07.018"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Srinivasan R. Infliximab treatment and pregnancy outcome in active Crohn's disease. Am J Gastroenterol 2001;96:2274-2275.","DOI":"10.1111\/j.1572-0241.2001.03987.x"},{"key":"ref4","unstructured":"Remicade product information. In: Physicians desk reference. 58th ed Montvale, NJ: Medical Economics Company, Inc; 2004;1145-1148."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Reddy JG, Loftus EV Jr. Safety of infliximab and other biologic agents in the inflammatory bowel diseases. Gastroenterol Clin North Am 2006;35:837-855.","DOI":"10.1016\/j.gtc.2006.09.008"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Simister NE. Placental transport of immunoglobulin G. Vaccine 2003;21:3365-3369.","DOI":"10.1016\/S0264-410X(03)00334-7"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005;21:733-738.","DOI":"10.1111\/j.1365-2036.2005.02405.x"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Friedman S, Regueiro MD. Pregnancy and nursing in inflammatory bowel disease. Gastroenterol Clin North Am 2002;31:265-73, xii.","DOI":"10.1016\/S0889-8553(01)00015-2"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004;99:2385-2392.","DOI":"10.1111\/j.1572-0241.2004.30186.x"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Tursi A. Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn's disease. Dig Liver Dis 2006;38:439-440.","DOI":"10.1016\/j.dld.2006.01.017"},{"key":"ref11","unstructured":"Humira (adalimumab) [prescribing information]. North Chicago, IL: Abbott Laboratories. 2005;."},{"key":"ref12","unstructured":"Sánchez Muñoz D, Hoyas Pablos E, Ramírez Martín Del Campo M, Núñez Hospital D, Guerrero Jiménez P. Term pregnancy in a patient with Crohn’s disease under treatment with adalimumab. Gastroenterol Hepatol 2005;28:435."},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut 2005;54:890.","DOI":"10.1136\/gut.2005.065417"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Sills ES, Perloe M, Tucker MJ, Kaplan CR, Palermo GD. Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis. Am J Reprod Immunol 2001;46:366-368.","DOI":"10.1034\/j.1600-0897.2001.d01-25.x"},{"key":"ref15","unstructured":"Ostensen M, Eigenmann GO. Etanercept in breast milk. J Rheumatol 2004;31:1017-1018."}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i19\/3085.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T16:09:05Z","timestamp":1557590945000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i19\/3085.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":15,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.14.3085","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}